GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HeartSciences HSCS · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.81

-10.84%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

HeartSciences — daily HSCS Delayed
Market value
$5.8m
Last close × shares
Volume
174.6k
Shares, 20 Nov 2026

About HeartSciences

From its filings with the US Securities and Exchange Commission

SEC filings

HeartSciences is based in Southlake, Texas and is incorporated in Texas. Its shares trade on Nasdaq under the ticker HSCS. The SEC classifies its business as finance services. In the fiscal year to 30 April 2026, it reported revenue of $4,319 and a net loss of $9.1m.

In its own words

We are a healthcare information technology company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”). Our first commercial product is MyoVista Insights™, a cloud-native, vendor- and device-agnostic ECG management platform designed to modernize ECG workflows and enable scalable deployment of AI-ECG capabilities across healthcare systems.

MyoVista Insights™ is classified as a Medical Device Data System (“MDDS”) and is exempt from the FDA 510(k) requirements. The platform is designed to streamline ECG study organization, enhance waveform analysis, and simplify clinical workflows, enabling more efficient interpretation, storage, and management of ECG data. It is also designed to host AI-ECG algorithms from multiple vendors and integrate them directly into clinical workflows, providing a flexible and extensible foundation for the adoption of AI in ECG.

Following its early adopter launch in 2025, we have implemented phased enhancements to MyoVista Insights™. In March 2026, we released a significant version upgrade for broader deployment across cardiology and healthcare IT environments. This release included mobile device access, enhanced reporting capabilities, and expanded interoperability designed to support integration across large health systems and enterprise environments.

Quoted from its 10-K, filed 23 Jul 2026. Read the filing on SEC.gov ↗

More about HeartSciences →

Latest on HeartSciences

Our reporting

Next results

10 Dec 2026

Due on 10 Dec 2026. Analysts expect earnings of -0.65 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is HeartSciences's ticker?

HeartSciences trades as HSCS on its US listing, under ISIN US42254E3027.

What was HeartSciences's last closing price?

1.81 on 20 Nov 2026. The figure is in USD and is never converted.

When does HeartSciences next report results?

Results are expected on 10 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.